Dick van Soolingen Selected Research

Dick van Soolingen Research Topics

Disease

54	Tuberculosis (Tuberculoses) 01/2022 - 01/2004
24	Infections 04/2022 - 11/2003
14	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021 - 05/2010
7	Extensively Drug-Resistant Tuberculosis 01/2020 - 06/2010
3	Lung Diseases (Lung Disease) 01/2016 - 07/2014
2	Coinfection 01/2018 - 01/2013
1	Chemical and Drug Induced Liver Injury 12/2018
1	Nontuberculous Mycobacterium Infections 10/2016
1	Ototoxicity 12/2015
1	Lymphadenitis (Adenitis) 10/2011
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2011
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2010
1	Weight Gain 06/2010
1	Pulmonary Tuberculosis 06/2010
1	Rheumatic Diseases (Rheumatism) 12/2008
1	Meningeal Tuberculosis (Tuberculous Meningitis) 11/2006
1	Leg Ulcer 11/2005
1	Cicatrix (Scar) 11/2005
1	Infection with Mycobacterium marinum 12/2002

Drug/Important Bio-Agent (IBA)

32	Pharmaceutical PreparationsIBA 04/2022 - 05/2007
12	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 08/2007
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 05/2009
8	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 08/2007
7	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 01/2004
7	Thioridazine (Mellaril)FDA LinkGeneric 01/2016 - 06/2010
4	VaccinesIBA 01/2020 - 01/2004
3	Moxifloxacin (Avelox)FDA Link 01/2022 - 08/2011
3	Pyrazinamide FDA LinkGeneric 11/2018 - 09/2010
3	Clarithromycin (Biaxin)FDA LinkGeneric 01/2017 - 12/2013
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2002
3	Linezolid (Zyvox)FDA Link 12/2013 - 08/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 07/2007
2	Ethambutol (Myambutol)FDA LinkGeneric 04/2022 - 08/2007
2	Levofloxacin (Levaquin)FDA Link 01/2017 - 10/2016
2	Ertapenem (Invanz)FDA Link 01/2017 - 04/2016
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2017 - 04/2016
2	Amikacin (A.M.K)FDA LinkGeneric 10/2016 - 12/2015
2	Antipsychotic Agents (Antipsychotics)IBA 01/2016 - 09/2010
2	CytokinesIBA 10/2013 - 10/2010
2	Antitubercular AgentsIBA 01/2012 - 02/2009
2	AntigensIBA 05/2010 - 04/2005
2	AntibodiesIBA 12/2008 - 04/2004
2	Biological ProductsIBA 12/2008 - 11/2003
1	MacrolidesIBA 04/2022
1	Interleukin-12 (IL 12)IBA 12/2019
1	AcetyltransferasesIBA 12/2018
1	Infliximab (Remicade)FDA Link 01/2018
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2017
1	Virulence Factors (Pathogenicity Factors)IBA 01/2017
1	Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric 10/2016
1	Biomarkers (Surrogate Marker)IBA 05/2016
1	Tigecycline (Tygacil)FDA Link 01/2016
1	Acetylcysteine (Siran)FDA LinkGeneric 11/2013
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 08/2013
1	1,3- dimethyl- 1,3- bis(4- fluorophenyl)- 1,3- bis(3- (1- (4- butypiperazinyl))propyl)disiloxaneIBA 05/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	SolutionsIBA 06/2012
1	FluoroquinolonesIBA 08/2011
1	Ciprofloxacin (Cipro)FDA LinkGeneric 08/2011
1	LipidsIBA 05/2010
1	Tumor Necrosis Factor InhibitorsIBA 12/2008
1	InterleukinsIBA 12/2008
1	Benzophenoneidum (Auramine O)IBA 07/2008
1	A-Form DNA (A-DNA)IBA 07/2008
1	lipoarabinomannan (LAM)IBA 04/2008
1	16S Ribosomal RNAIBA 03/2008
1	Streptomycin (Streptomycin Sulfate)FDA Link 08/2007
1	Colloids (Colloid)IBA 11/2005
1	Listeria monocytogenes hlyA protein (listeriolysin O)IBA 09/2005
1	AerosolsIBA 09/2005
1	Subunit VaccinesIBA 04/2005
1	Explosive Agents (Explosives)IBA 07/2004
1	Interferon-gamma (Interferon, gamma)IBA 07/2004
1	Tuberculin (PPD)IBA 12/2002

Therapy/Procedure

10	Therapeutics 10/2016 - 11/2005
2	Drug Therapy (Chemotherapy) 01/2015 - 11/2003
2	Duration of Therapy 05/2013 - 08/2011
1	Aftercare (After-Treatment) 10/2010
1	Oral Administration 09/2010